The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury

Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in FemalesNovelty and Significance

(2016) Guanghong Jia et al.   CIRCULATION RESEARCH

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

(2016) Gerasimos Filippatos et al.   EUROPEAN HEART JOURNAL

Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial InfarctionNovelty and Significance

(2016) Alexandre Gueret et al.   HYPERTENSION

Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2016) Hai-Ha Le et al.   PLoS One

Nonsteroidal antagonists of the mineralocorticoid receptor

(2015) Peter Kolkhof et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

The Global Burden of Ischemic Heart Disease in 1990 and 2010

(2014) Andrew E. Moran et al.   CIRCULATION

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study

(2014) G. Montalescot et al.   EUROPEAN HEART JOURNAL

Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors

(2013) Dafina Pruthi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Mineralocorticoid receptor antagonists for therapy of coronary artery disease and related complications

(2013) Carolin Zwadlo et al.   CURRENT OPINION IN PHARMACOLOGY

The ARTS of third-generation mineralocorticoid receptor antagonists: achieving cardiovascular benefit with minimized renal side effects?

(2013) Johann Bauersachs   EUROPEAN HEART JOURNAL

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

(2013) Bertram Pitt et al.   EUROPEAN HEART JOURNAL

Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation

(2012) Jan-Marcus Daniel et al.   BASIC RESEARCH IN CARDIOLOGY

Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases

(2012) Lars Bärfacker et al.   ChemMedChem

Eplerenone Reduced Lesion Size in Early but Not Advanced Atherosclerosis in Apolipoprotein E–Deficient Mice

(2012) Ayelet Raz-Pasteur et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression

(2011) Julie Favre et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction

(2011) Daniela Fraccarollo et al.   CIRCULATION

Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure

(2011) Fabrice Ivanes et al.   EUROPEAN HEART JOURNAL

Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States

(2011) Ian H. de Boer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION